626 Financial LLC Sells 3,136 Shares of Stryker Corporation $SYK

626 Financial LLC lessened its position in Stryker Corporation (NYSE:SYK) by 3.9% in the 3rd quarter, Holdings Channel reports. The fund owned 77,003 shares of the medical technology company’s stock after selling 3,136 shares during the period. Stryker accounts for approximately 12.5% of 626 Financial LLC’s holdings, making the stock its biggest position. 626 Financial LLC’s holdings in Stryker were worth $28,466,000 at the end of the most recent quarter.

Several other large investors have also recently added to or reduced their stakes in the company. Brighton Jones LLC increased its position in Stryker by 15.4% during the 4th quarter. Brighton Jones LLC now owns 4,564 shares of the medical technology company’s stock worth $1,643,000 after purchasing an additional 609 shares during the period. Chicago Partners Investment Group LLC boosted its stake in shares of Stryker by 6.1% in the second quarter. Chicago Partners Investment Group LLC now owns 3,852 shares of the medical technology company’s stock valued at $1,544,000 after buying an additional 220 shares in the last quarter. WBH Advisory Inc. acquired a new position in Stryker during the second quarter worth $212,000. Schnieders Capital Management LLC. purchased a new position in Stryker in the second quarter worth $205,000. Finally, Princeton Global Asset Management LLC lifted its holdings in Stryker by 16.9% in the second quarter. Princeton Global Asset Management LLC now owns 180 shares of the medical technology company’s stock valued at $71,000 after acquiring an additional 26 shares during the period. 77.09% of the stock is owned by hedge funds and other institutional investors.

Insider Buying and Selling

In other news, CFO Preston Wendell Wells sold 165 shares of Stryker stock in a transaction on Thursday, November 20th. The stock was sold at an average price of $365.88, for a total value of $60,370.20. Following the completion of the sale, the chief financial officer owned 6,694 shares of the company’s stock, valued at $2,449,200.72. The trade was a 2.41% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Ronda E. Stryker sold 250,000 shares of the company’s stock in a transaction on Wednesday, February 4th. The shares were sold at an average price of $362.92, for a total value of $90,730,000.00. Following the completion of the transaction, the director owned 2,457,331 shares of the company’s stock, valued at $891,814,566.52. The trade was a 9.23% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. 5.90% of the stock is currently owned by company insiders.

Stryker Stock Up 0.8%

Shares of NYSE:SYK opened at $369.13 on Wednesday. The company has a quick ratio of 1.21, a current ratio of 1.89 and a debt-to-equity ratio of 0.66. The company has a market capitalization of $141.26 billion, a P/E ratio of 43.94, a P/E/G ratio of 2.14 and a beta of 0.87. Stryker Corporation has a 52-week low of $329.16 and a 52-week high of $404.87. The stock’s fifty day simple moving average is $358.66 and its 200-day simple moving average is $368.87.

Stryker (NYSE:SYK) last announced its earnings results on Thursday, January 29th. The medical technology company reported $4.47 earnings per share for the quarter, beating the consensus estimate of $4.40 by $0.07. The firm had revenue of $7.17 billion during the quarter, compared to the consensus estimate of $7.12 billion. Stryker had a net margin of 12.92% and a return on equity of 24.41%. The firm’s revenue for the quarter was up 11.4% on a year-over-year basis. During the same quarter in the previous year, the company posted $4.01 EPS. As a group, equities research analysts forecast that Stryker Corporation will post 13.47 earnings per share for the current fiscal year.

Stryker Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Thursday, April 30th. Investors of record on Tuesday, March 31st will be paid a dividend of $0.88 per share. The ex-dividend date of this dividend is Tuesday, March 31st. This represents a $3.52 annualized dividend and a dividend yield of 1.0%. Stryker’s dividend payout ratio is presently 41.90%.

Wall Street Analyst Weigh In

SYK has been the subject of a number of research analyst reports. Evercore set a $390.00 price target on shares of Stryker in a report on Monday, January 5th. Citigroup restated a “market outperform” rating on shares of Stryker in a research report on Friday, January 30th. Wells Fargo & Company lifted their price target on shares of Stryker from $452.00 to $456.00 and gave the company an “overweight” rating in a research report on Friday, November 14th. Weiss Ratings reissued a “hold (c+)” rating on shares of Stryker in a research note on Monday, December 22nd. Finally, Raymond James Financial raised Stryker from a “market perform” rating to an “outperform” rating and set a $418.00 price objective for the company in a research note on Tuesday, January 6th. Twelve equities research analysts have rated the stock with a Buy rating and four have given a Hold rating to the company’s stock. According to MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus price target of $426.94.

About Stryker

Stryker Corporation is a global medical technology company that designs, manufactures and markets a broad range of products and services for use in hospitals, surgeons’ offices and other healthcare facilities. Its primary business activities span orthopedics (including joint replacement implants, trauma and extremities products), surgical equipment and operating room technologies (such as visualization, navigation and powered instruments), neurotechnology and spine solutions, and patient-handling and emergency medical equipment.